{
    "Trade/Device Name(s)": [
        "ACE Axcel Clinical Chemistry System",
        "ACE Cholesterol Reagent",
        "ACE HDL-C Reagent",
        "ACE LDL-C Reagent",
        "ACE Triglycerides Reagent"
    ],
    "Submitter Information": "Alfa Wassermann Diagnostic Technologies, LLC",
    "510(k) Number": "K113262",
    "Predicate Device Reference 510(k) Number(s)": [
        "K931786",
        "K971526",
        "K991733"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JJE",
        "CHH",
        "LBS",
        "MRR",
        "CDT"
    ],
    "Summary Letter Date": "May 31, 2012",
    "Summary Letter Received Date": "June 1, 2012",
    "Submission Date": "November 3, 2011",
    "Regulation Number(s)": [
        "21 CFR 862.2610",
        "21 CFR 862.1175",
        "21 CFR 862.1475",
        "21 CFR 862.1705"
    ],
    "Regulation Name(s)": [
        "Analyzer, Chemistry (Photometric, Discrete), For Clinical Use",
        "Cholesterol (total) test system",
        "LDL & VLDL Precipitation, Cholesterol Via Esterase-Oxidase, HDL",
        "Lipase Hydrolysis/Glycerol Kinase Enzyme, Triglycerides"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Cholesterol",
        "HDL Cholesterol",
        "LDL Cholesterol",
        "Triglycerides"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "ACE Axcel Clinical Chemistry System"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic Esterase-Oxidase (for Cholesterol/HDL-C/LDL-C)",
        "Lipase Hydrolysis/Glycerol Kinase Enzyme (for Triglycerides)",
        "Photometric detection"
    ],
    "Methodologies": [
        "Optical absorbance measurement",
        "Enzymatic colorimetric assay"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Reagent",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for ACE Axcel Clinical Chemistry System and associated reagents for quantitative analysis of cholesterol, HDL-C, LDL-C, and triglycerides in serum.",
    "Indications for Use Summary": "Intended for quantitative determination of cholesterol, HDL cholesterol, LDL cholesterol, and triglyceride concentrations in serum for diagnosis and treatment of lipid, metabolic, and endocrine disorders in clinical laboratories or physician office laboratories; for in vitro diagnostic use only.",
    "fda_folder": "Clinical Chemistry"
}